Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)
CNY 113.48
(-0.65%)
CNY 113.48
(-0.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.17 Billion CNY | 31.08% |
| 2022 | 896.5 Million CNY | 30.95% |
| 2021 | 684.63 Million CNY | 45.59% |
| 2020 | 470.25 Million CNY | 40.91% |
| 2019 | 333.73 Million CNY | 44.39% |
| 2018 | 231.12 Million CNY | 39.96% |
| 2017 | 165.13 Million CNY | 31.76% |
| 2016 | 125.32 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 424.51 Million CNY | 19.78% |
| 2024 Q1 | 354.41 Million CNY | 19.82% |
| 2024 Q3 | 181.89 Million CNY | -57.15% |
| 2023 Q4 | 295.8 Million CNY | 10.86% |
| 2023 Q3 | 266.83 Million CNY | -20.59% |
| 2023 Q2 | 336.03 Million CNY | 17.66% |
| 2023 FY | 1.17 Billion CNY | 31.08% |
| 2023 Q1 | 285.59 Million CNY | 22.97% |
| 2022 Q2 | 200.92 Million CNY | -22.09% |
| 2022 Q1 | 257.87 Million CNY | 47.81% |
| 2022 Q3 | 205.44 Million CNY | 2.25% |
| 2022 FY | 896.5 Million CNY | 30.95% |
| 2022 Q4 | 232.25 Million CNY | 13.05% |
| 2021 Q3 | 147.88 Million CNY | -10.27% |
| 2021 Q4 | 174.47 Million CNY | 17.98% |
| 2021 FY | 684.63 Million CNY | 45.59% |
| 2021 Q2 | 164.8 Million CNY | -16.54% |
| 2021 Q1 | 197.46 Million CNY | 38.99% |
| 2020 Q2 | 115.64 Million CNY | 16.59% |
| 2020 Q1 | 99.19 Million CNY | 15.14% |
| 2020 FY | 470.25 Million CNY | 40.91% |
| 2020 Q4 | 142.06 Million CNY | 25.35% |
| 2020 Q3 | 113.34 Million CNY | -2.0% |
| 2019 Q3 | 75.64 Million CNY | -5.25% |
| 2019 Q2 | 79.82 Million CNY | -13.34% |
| 2019 Q1 | 92.11 Million CNY | 58.12% |
| 2019 FY | 333.73 Million CNY | 44.39% |
| 2019 Q4 | 86.14 Million CNY | 13.89% |
| 2018 Q1 | 66.53 Million CNY | 0.0% |
| 2018 FY | 231.12 Million CNY | 39.96% |
| 2018 Q4 | 58.25 Million CNY | 13.18% |
| 2018 Q3 | 51.47 Million CNY | -6.17% |
| 2018 Q2 | 54.86 Million CNY | -17.55% |
| 2017 FY | 165.13 Million CNY | 31.76% |
| 2016 FY | 125.32 Million CNY | 0.0% |